If a pharmacist learns of an adverse event or a suspected defective drug product involving compounded preparations the pharmacy prepared, it shall without delay report this information to the board and any and all licensed veterinarians to whom, according to the pharmacy's records, the compounded preparation was provided. The pharmacist should also notify the U.S. Food and Drug Administration of any adverse event or product defect associated with the use of the drug within fifteen (15) days.
02-392 C.M.R. ch. 42, § 6